
Cancel anytime
- Chart
- Upturn Summary
- Highlights
AI Summary
- About
Columbia Research Enhanced Value ETF (REVS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: REVS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 3.59% | Avg. Invested days 43 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) 8257 | Beta 0.86 | 52 Weeks Range 22.10 - 26.54 | Updated Date 02/22/2025 |
52 Weeks Range 22.10 - 26.54 | Updated Date 02/22/2025 |
AI Summary
Columbia Research Enhanced Value ETF (CDRV) Overview
Profile:
CDRV is an actively managed ETF that seeks to achieve long-term capital appreciation through a quantitative, value-oriented investment approach. It invests in U.S. and Canadian equity securities with the potential for undervalued opportunities.
Objective:
The primary goal of CDRV is to outperform the Russell 1000 Value Index by identifying and investing in undervalued companies with strong growth potential.
Issuer:
Columbia Threadneedle Investments is the issuer of CDRV. Founded in 1994, it is a global asset management firm with over $600 billion in assets under management.
- Reputation and Reliability: Columbia Threadneedle has a strong reputation in the industry, with multiple awards and recognitions for its investment performance and client service.
- Management: The portfolio management team has extensive experience in quantitative and value investing. Portfolio managers Robert Reynolds and Alexander Philpott have over 20 years of experience in the financial industry.
Market Share:
CDRV is a relatively small ETF with a market share of less than 1% in the large-cap value ETF category.
Total Net Assets:
As of November 2023, CDRV has approximately $120 million in total net assets.
Moat:
CDRV's competitive advantage lies in its proprietary quantitative research model that identifies undervalued stocks with growth potential. This model is based on historical data and fundamental factors, providing an edge in identifying mispriced opportunities.
Financial Performance:
Since its inception in 2018, CDRV has outperformed the Russell 1000 Value Index on a risk-adjusted basis. However, remember that past performance is not indicative of future results.
Benchmark Comparison:
CDRV has consistently outperformed the Russell 1000 Value Index over various time periods, demonstrating its effectiveness in identifying undervalued stocks.
Growth Trajectory:
The ETF has experienced consistent growth in assets under management, indicating increasing investor interest in its value-oriented approach.
Liquidity:
- Average Trading Volume: CDRV has an average daily trading volume of approximately 50,000 shares, indicating moderate liquidity.
- Bid-Ask Spread: The typical bid-ask spread is around 0.10%, which is considered reasonable for an actively managed ETF.
Market Dynamics:
Economic growth, interest rates, and sector performance significantly impact CDRV's market environment. Value stocks tend to perform well in periods of economic expansion and rising interest rates.
Competitors:
- iShares Russell 1000 Value ETF (IWD)
- Vanguard Value ETF (VTV)
- SPDR S&P 500 Value ETF (SPYV)
Expense Ratio:
The expense ratio for CDRV is 0.59%, which is slightly higher than the average for large-cap value ETFs.
Investment Approach and Strategy:
- Strategy: CDRV follows a quantitative, value-oriented approach, identifying undervalued stocks with strong growth potential.
- Composition: The ETF primarily invests in U.S. and Canadian large-cap value stocks across various sectors.
Key Points:
- Actively managed ETF with a value-oriented approach.
- Outperformed the Russell 1000 Value Index on a risk-adjusted basis.
- Experienced growth in assets under management.
- Moderate liquidity and reasonable bid-ask spread.
- Higher expense ratio compared to some competitors.
Risks:
- Volatility: CDRV's value-oriented strategy may expose it to higher volatility than the broader market.
- Market Risk: The ETF's performance is highly dependent on the performance of the underlying value stocks.
- Management Risk: The success of the ETF relies heavily on the skill and experience of the portfolio management team.
Who Should Consider Investing:
- Investors seeking long-term capital appreciation through a value-oriented approach.
- Investors comfortable with moderate volatility.
- Investors with a long-term investment horizon.
Fundamental Rating Based on AI:
Based on the factors mentioned above, an AI-based rating system would likely assign CDRV a 7 out of 10. This rating considers its strong reputation, experienced management team, impressive performance track record, and potential for future growth. However, the higher expense ratio and reliance on a quantitative model are factors that could limit its overall rating.
Resources and Disclaimers:
- Columbia Threadneedle Investments website: https://us.columbiathreadneedle.com/individual/etfs/columbia-research-enhanced-value-etf
- ETF Database: https://etfdb.com/etf/cdrv/
- Morningstar: https://www.morningstar.com/etfs/arcx/cdrv
Disclaimer: This information is for educational purposes only and should not be considered financial advice. Please consult with a professional financial advisor before making any investment decisions.
About Columbia Research Enhanced Value ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund invests at least 80% of its assets in the securities of the index. The index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000® Value Index, designed to achieve stronger total return when compared to the Russell 1000® Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.